Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rethink Mental Illness is a prominent United Kingdom-based mental health charity and social care provider dedicated to supporting individuals affected by severe mental illness. Founded in 1972 as the National Schizophrenia Fellowship, the organization operates over 200 services across England, including crisis houses, supported housing, and community support groups. Beyond direct service provision, Rethink is a major advocacy body that campaigns for policy reform and works to reduce the social stigma associated with mental health conditions. They provide expert advice and information to tens of thousands of people annually, helping them navigate the mental health system and access legal and financial support. The organization also co-founded Mental Health UK, a network of charities working together to improve the lives of people across the four nations of the UK.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rethink Mental Illness.